Showing 1 - 3 results of 3 for search 'Kathryn J Newhall', query time: 0.02s Refine Results
  1. 1
    Immunomodulation by durvalumab and pomalidomide in patients with relapsed/refractory multiple myeloma

    Immunomodulation by durvalumab and pomalidomide in patients with relapsed/refractory multiple myeloma by Mary H. Young, Greg Pietz, Elizabeth Whalen, Wilbert Copeland, Ethan Thompson, Brian A. Fox, Kathryn J. Newhall

    Published 2021-08-01
    Get full text
    Article
  2. 2
    The Broad Anti-AML Activity of the CD33/CD3 BiTE Antibody Construct, AMG 330, Is Impacted by Disease Stage and Risk.

    The Broad Anti-AML Activity of the CD33/CD3 BiTE Antibody Construct, AMG 330, Is Impacted by Disease Stage and Risk. by Kimberly H Harrington, Chelsea J Gudgeon, George S Laszlo, Kathryn J Newhall, Angus M Sinclair, Stanley R Frankel, Roman Kischel, Guang Chen, Roland B Walter

    Published 2015-01-01
    Get full text
    Article
  3. 3
    Efficacy and Safety of Durvalumab Combined with Daratumumab in Daratumumab-Refractory Multiple Myeloma Patients

    Efficacy and Safety of Durvalumab Combined with Daratumumab in Daratumumab-Refractory Multiple Myeloma Patients by Kristine A. Frerichs, Christie P. M. Verkleij, Meletios A. Dimopoulos, Jhon A. Marin Soto, Sonja Zweegman, Mary H. Young, Kathryn J. Newhall, Tuna Mutis, Niels W. C. J. van de Donk

    Published 2021-05-01
    Get full text
    Article

Search Tools: